High incidence of zidovudine induced anaemia in HIV infected patients in eastern India

Indian Journal of Medical Research

Volumn 132, Issue 10, 2010, Pages 386-389

  Agarwal, Dipti ^a   Chakravarty, Jaya ^a   Chaube, Lavina ^a   Rai, Madhukar ^a   Agrawal, Nisha Rani ^a   Sundar, Shyam ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Anaemia; Antiretroviral therapy; HIV infection; Zidovudine

Indexed keywords

HEMOGLOBIN; STAVUDINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ANEMIA; ANTIVIRAL THERAPY; ARTICLE; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; METABOLISM; MYELOID PROGENITOR CELL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGE FACTORS; ANEMIA; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HEMOGLOBINS; HUMANS; INDIA; MALE; MYELOID PROGENITOR CELLS; PREVALENCE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; SEX FACTORS; ZIDOVUDINE;

EID: 78049469747     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. World Health Organization. Scaling Up Antiretroviral Therapy in Renounce Limited Settings: Treatment Guidelines for a Public Health Approach -2003. Revision available at: http://www.whoint/3by5/publications/guidelines/en/execsumm.pdf, accessed on December 10, 2008.
2. Operational Guidelines on ART Centres, March 2007. Available at: http://www.nacoonline.org/About_NACO/Policy_Guidelines/, accessed on December 28, 2008.
3. Moore RD, Creagh-Kirk T, Keruly J, Link G, Wang MC, Richman D, et al. Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group. Arch Intern Med 1991; 151: 981-986.
4. Kumarasamy N, Venkatesh KK, Cecelia AJ, Devaleeval B, Lai AR, Saghayam S, et al. Spectrum of adverse events after generic HAART in Southern Indian HIV-infected patients. AIDS Patients Care STDS 2008; 22:337-344.
5. Moh R, Danel C, Sorho S, Sauvageot D, Anzian A, Minga A, et al. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire. Antiviral Therapy 2005; 10: 615-624.
6. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV related disease in adult and children. WHO. 2006. Available at: http://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf, accessed on November 18, 2008.
7. Isaakidis P, Raguenaud ME, Phe T, Khim SA, Kuoch S, Khem S, et al. Evaluation of a systemic substitution of zidovudine for stavudine-based HAART in a program setting in rural Combodia. J Acquir Immune Defic Syndr 2008; 49: 48-54.
8. van Leeuwen R, van den Hurk PJ, Jöbsis GJ, van der Wouw PA, Reiss P, Eeftinck Schattenkerk JK, et al. Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infection. Genitourin Med 1990; 66: 418-422.
9. th ed. Paris: Flying Publisher; 2006. p. 94-130.
10. van der Werf MJ, van Benthem BH, van Ameijden EJ. Prevalence, incidence and risk factors of anaemia in HIV-positive and HIV-negative drug users. Addiction 2000; 95: 383-392.
11. Ssali F, Stöhr W, Munderi P, Reid A, Walker AS, Gibb DM, et al; DART Trial Team. Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. Antivir Ther 2006; 11: 741-749.
12. Curkendall SM, Richardson JT, Emons MF, Fisher AE, Everhard F. Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy. HIV Med 2007; 8: 483-490.
13. Huffam S E, Srasuebkul P, Zhou J, Calmy A, Saphonn V, Kaldor JM, et al; TREAT Asia HIV Observational Database (TAHOD). Prior antiretroviral therapy experience protects against zidovudine-related anaemia. HIV Med 2007; 8: 465-471.
14. Aurpibul L, Puthanakit T, Sirisanthana T, Sirisanthana V. Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy. HIV Med 2008; 9: 317-321.